PRECISION BIOSCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 3.20K shares, a 71.43% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 11.19K shares, a 99.44% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 0.00 shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-12 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -48.30K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-13 | -48.30K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | -48.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 3.20K shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -267.68K shares derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -248.56K shares derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-03-31 | 51.49K shares 10-Q · filed 2023-05-09 | -170.32K shares derived: sum of 4 quarters · filed 2024-03-27 |
| 2022-12-31 | -319.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 11.19K shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 19.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 470.43K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | 78.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 865.38K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | 233.00K shares 10-Q · filed 2022-05-09 | 1.55M shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | 140.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 2.00M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 414.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 2.08M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-06-30 | 766.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.88M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-03-31 | 676.79K shares 10-Q · filed 2021-05-13 | 1.84M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-12-31 | 217.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 1.41M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 222.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 1.69M shares derived: sum of 4 quarters · filed 2021-03-18 |
| 2020-06-30 | 725.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 1.54M shares derived: sum of 4 quarters · filed 2021-03-18 |
| 2020-03-31 | 245.00K shares 10-Q · filed 2020-05-15 | 1.04M shares derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-12-31 | 495.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 940.94K shares 10-K · filed 2021-03-18 |
| 2019-09-30 | 69.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2019-06-30 | 230.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2019-03-31 | 145.97K shares 10-Q · filed 2019-04-29 | |
| 2018-12-31 | 220.31K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |